Словенија - Словеначки - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

norbrook laboratories (ireland) limited rossmore industrial estate monaghan irska proizvajalec odgovoren za sproščanje serij: norbrook manufacturing ltd -

Европска Унија - Словеначки - EMA (European Medicines Agency)

virbac s.a. - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

ceva santé animale - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

vetoquinol - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

sanofi pasteur - influenza a virus subtype h1n1 haemagglutinin, recombinant, influenza a virus subtype h3n2 haemagglutinin, recombinant, influenza b virus victoria lineage haemagglutinin, recombinant, influenza b virus yamagata lineage haemagglutinin, recombinant - gripa, človek - cepiva - supemtek is indicated for active immunization for the prevention of influenza disease in adults. supemtek should be used in accordance with official recommendations.

Европска Унија - Словеначки - EMA (European Medicines Agency)

elanco gmbh - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

vmd n.v. - tulatromicin - antibacterials for systemic use, macrolides - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

dechra regulatory b.v. - tulatromicin - antibakterij za sistemsko uporabo - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin. pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. prisotnost bolezni v čredi je treba določiti pred metafilaktičnim zdravljenjem. the product should only be used if pigs are expected to develop the disease within 2–3 days. ovce: zdravljenje zgodnjih fazah nalezljivih pododermatitis (stopala gnilobe), ki je povezana s sovražno dichelobacter nodosus, ki zahteva sistemsko zdravljenje.

Европска Унија - Словеначки - EMA (European Medicines Agency)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - cepiva - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. uporaba tega cepiva mora biti v skladu z uradnimi priporočili.

Словенија - Словеначки - Ecolab

ecolab deutschland gmbh -